Panorama scans the third batch of national band procurement key points.

Introduction: The interpretation of the key points of national harvest.
the rivers and lakes of medicine will eventually be written by someone.
yesterday, the third batch of the country with volume procurement program officially issued, the author combined with the relevant policies of the country to the key points of the national collection for the reader's reference.
1 Background Recently, the State Administration of Health Insurance issued the 2019 National Medical Security Development Statistics Bulletin, improving the efficiency of medical insurance use is still the main theme of the future.
in drug procurement, as of the end of 2019, the average completion of the agreed procurement of 25 selected drugs in the pilot areas of "4 plus 7" drug centralized import sourcing, and the procurement of selected drugs accounted for 78% of the same generic drug procurement volume.
the pilot national expansion, 25 generic varieties of all the expansion of the procurement success, the expansion price decreased by an average of 59%, in the "4 plus 7" pilot based on a 25% reduction.
to volume exchange price, speed up the replacement, purify the space, value for the king has become an irreversible collection trend.
2 comparative source: national belt procurement documents, watchmaking: wind light 3 over evaluation finishing: wind light 4 competition according to the document, the relevant enterprises need to be "unit comparable price" from low to high to determine the declaration of enterprises shortlisted and the order of supply area confirmation.
(1) 2019 provincial supply areas more enterprises priority (based on local data) ;( analysis: to ensure clinical supply, with radiation coverage, is a necessary reference condition) (2) 2019 in the local sales of large enterprises priority, multiple specifications of varieties, sales combined calculation (based on local data) ;( analysis: in the market width On the basis of measuring market thickness( (3) through or as if through the State Drug Administration generic drug quality and efficacy consistency evaluation time in the first enterprise priority (subject to the approval date of the State Drug Administration) ;( analysis: speed up, encourage priority overevaluation) (4) api-based production of raw materials enterprises priority (limited to the raw materials and preparations production enterprises as the same legal person).
(analysis: still guarantees supply, if there is a clinical shortage, drug price credit evaluation mechanism will be effective).
it is not difficult to see that, following the expansion of the joint mining, the buyer has been on the relevant procurement rules light car familiar road, the football league de-listing system reproduction of drug procurement, through the document requirements can basically judge: joint selection decision-makers have basically touched the red line of the bidding enterprise, and, low-cost winning enterprises have alternately choose the right to the province, this is like the football match, the first by the winning bid (the lowest bid price) party to choose the first, but a number of the first
but the biggest problem is that if a maximum of 8 enterprises are allowed to win the bid, then each enterprise 3-4 provinces of the choice, although there is "do not encourage large price cuts, more than to win the market" of the initial mind, but it is easy to cause two extremes, either walk through the field, symbolic quotation selling off the bid;
5 strategy according to the document, each variety of the first year agreed purchase volume according to the following rules: the actual number of enterprises in the country is 1, for the first year agreed to purchase the calculation of 50% of the base; 60% of the base of the calculation of the purchase volume, the number of enterprises in the actual national election is 3, for the first year of the agreed purchase volume calculation base of 70%, the number of actual enterprises in the country is 4 or more, for the first year of the agreed purchase amount calculation base of 80%.
among them amoxicillin granules, linaimine oral change agent type, mosisac sodium chloride injection, left oxyfluorasin oral pascoe eye drops, cephalosporini oral pascoa release agent type, cephalosporine oral frequent release agent type, kramycin oral asanophine type of first-year agreed purchase volume according to the following rules: national actual selection of the following rules The number of enterprises is 1, for the first year agreed to purchase volume calculation base of 40%;
this will be a balancing act for the bidding business.
a variety of situations actually require careful measurement by the enterprise.
such as the unit comparable price price of the decline and its own price, these levels, enterprises should consider whether their own price system can bear, and the unit can be priced with the same variety of 1.8 times the distance need to observe the price fluctuations of the opponent, and for the generic drug preparations, who has mastered the raw materials, who can hold their own lifeline.
the cost of API is the core of pharmaceutical companies to consider, in order to reduce prices, we must first consider the API.
overall, this price decision cannot be considered in isolation and should be taken into account from an extreme point of view, taking into account the factors that arise if the offer is the same.
according to the policy, the relevant established market will be divided by the selected enterprises, even if there is a surplus market, for the products not selected are almost compressed to nothing.
the remaining stock market is basically left to the original research and three products, in theory, but each hospital is also hundreds of boxes, no scale representatives can not afford! For companies, the concern is that if prices continue to fall this way, the risk of companies succumbing to the risk of cost-cutting quality will come after winning the bid and supply problems, including the supply of API.
and from the point of view of the drug market license holder, the risk of being responsible for the entire life cycle of the drug and assuming the corresponding legal liability is the one that the holder must consider.
6 differential ratio, such as the difference ratio repeatedly emphasized in the procurement of national belt quantities.
this document mentioned five difference ratio, suggested that market access personnel must be careful, the joint procurement office will still hold a ventilation meeting before the standard, the relevant enterprises must ask through, ask understand.
a lot of countries to pick a batch of two batches of winning enterprises, in fact, to the winning bid at that moment, is still confused in the cast, confused in the middle.
this, the enterprise should have a number in mind, do a good job of detail.
.